BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Patent Owner
Stats
- 1,110 US PATENTS IN FORCE
- 37 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 1,110 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 36,701 Total Citation Count
- Mar 31, 1977 Earliest Filing
- 931 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0002,312 TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASESJan 07, 16Jan 04, 18[A61K, C07F, C07D]
2017/0266,152 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOFMar 13, 17Sep 21, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9920035 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereofAug 05, 15Mar 20, 18[C07D]
9907756 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivativeJul 07, 16Mar 06, 18[A61K]
9884854 N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamidesApr 12, 17Feb 06, 18[C07D]
9873714 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivativesApr 07, 15Jan 23, 18[C07H, C07D]
9867831 Combination treatment of acute myeloid leukemia and myelodysplastic syndromeSep 21, 15Jan 16, 18[A61K]
9845314 Pyrazolyl-substituted heteroaryls and their use as medicamentsSep 02, 16Dec 19, 17[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0050,992 NOVEL ANNELATED PHENOXYACETAMIDESAbandonedAug 19, 16Feb 23, 17[A61K, C07F, C07D, C07C]
2016/0052,938 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORSAbandonedAug 20, 15Feb 25, 16[A61K, C07D]
2016/0032,006 THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTSAbandonedFeb 12, 14Feb 04, 16[A61K, G01N, C07K]
2016/0016,990 PROTEIN PURIFICATION BY MEANS OF AQUEOUS TWO-PHASE CENTRIFUGAL EXTRACTIONAbandonedFeb 26, 14Jan 21, 16[C07K, B01D]
2016/0000,816 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOFAbandonedSep 16, 15Jan 07, 16[A61K]
2015/0150,982 PHARMACEUTICAL FORMULATION FOR A THERAPEUTIC ANTIBODYAbandonedJun 12, 13Jun 04, 15[A61K, C07K]
2015/0038,532 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral AdministrationAbandonedOct 17, 14Feb 05, 15[A61K]
2015/0031,642 COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IAbandonedJul 24, 14Jan 29, 15[A61K]
2015/0031,643 COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IIAbandonedJul 24, 14Jan 29, 15[A61K]
2015/0005,350 ADMINISTRATION OF ETHYL 3-[(2--1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)PYRIDIN-2-YLAMINO]PROPIONATEAbandonedSep 18, 14Jan 01, 15[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.